NCT03424018: An ongoing trial by BioMarin Pharmaceutical
This trial is ongoing. It must report results 6 years, 6 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT03424018 |
|---|---|
| Title | A Phase 3, Open-Label Long-Term Extension Study to Evaluate the Safety and Efficacy of BMN 111 in Children With Achondroplasia |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Dec. 12, 2017 |
| Completion date | June 30, 2031 |
| Required reporting date | June 29, 2032, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |